PDND
Phytochemical Database for Neurological Disorders
search icon
Advanced search

Phytochemical Name : Salicylamide
PCNDIDS0012
Pubchem CID : 5147
Molecular formula: C7H7NO2

Molecular weight : 137.140

Canonical SMILES : C1=CC=C(C(=C1)C(=O)N)O

Synonymes : salicylamide|2-Hydroxybenzamide|65-45-2|o-Hydroxybenzamide|2-Carbamoylphenol|Salicylic acid amide|Benzamide, 2-hydroxy-|Salamide|Urtosal|2-Carboxamidophenol|Algiamida|Amidosal|Dolomide|Dropsprin|Eggosalil|Flarpirina|Liquiprin|Morsarinas|Panithal|Raspberin|Saliamid|Saliamin|Salizell|Serramida|Algamon|Allevin|Anamid|Andasol|Novecyl|Oramid|Salamid|Salicim|Salipur|Salrin|Salymid|Acket|Afko-Sal|Amid-Sal|Benzamide, o-hydroxy-|Salicilamida|Salicilamide|Salicylamidum|Amid kyseliny salicylove|Salizell (VAN)|Benesal (VAN)|NSC 3115|OHB|Salicilamide [DCIT]|Salicilamide [Italian]|Salicylamid|CCRIS 6045|HSDB 227|Samid|H.P. 34|SR 4326|Benzoic acid, 2-hydroxy-, amide|UNII-EM8BM710ZC|NSC-3115|Salicylamidum [INN-Latin]|EINECS 200-609-3|Salicilamida [INN-Spanish]|EM8BM710ZC|MFCD00007978|2-Hydroxy-benzamide|BRN 0742439|DTXSID3021726|CHEBI:32114|AI3-03454|Amid kyseliny salicylove [Czech]|CHEMBL27577|Salicylamide [INN:BAN:JAN]|MLS000069486|DTXCID501726|EC 200-609-3|Salicylamide [USP:INN:BAN:JAN]|4-10-00-00169 (Beilstein Handbook Reference)|NCGC00091414-02|SMR000046394|Salicylamide 100 microg/mL in Acetonitrile|SALICYLAMIDE (MART.)|SALICYLAMIDE [MART.]|SALICYLAMIDE (USP-RS)|SALICYLAMIDE [USP-RS]|SALICYLAMIDE (USP MONOGRAPH)|SALICYLAMIDE [USP MONOGRAPH]|CAS-65-45-2|salicylamid-|hydroxy benzamide|Saliclamide,(S)|dihydroxybenzalamine|2-oxidanylbenzamide|Salicylamide (TN)|Salicylamide, 99%|Spectrum_000946|Opera_ID_1684|Spectrum2_001312|Spectrum3_000564|Spectrum4_000499|Spectrum5_001032|SALICYLAMIDE [MI]|WLN: ZVR BQ|SALICYLAMIDE [INN]|SALICYLAMIDE [JAN]|SALICYLAMIDE [HSDB]|SALICYLAMIDE [INCI]|NCIOpen2_001127|SALICYLAMIDE [VANDF]|Oprea1_069894|SCHEMBL21646|BSPBio_001948|KBioGR_001017|KBioSS_001426|DivK1c_000858|SALICYLAMIDE [WHO-DD]|SPECTRUM1500532|Salicylamide (JAN/USP/INN)|Salicylamide [BAN:INN:JAN]|SPBio_001403|HMS502K20|KBio1_000858|KBio2_001426|KBio2_003994|KBio2_006562|KBio3_001448|N02BA05|NSC3115|NINDS_000858|HMS1920P14|HMS2092G15|HMS2232E07|Pharmakon1600-01500532|component of Tolagesic (Salt/Mix)|HY-B0811|Tox21_111129|Tox21_201944|Tox21_302801|BBL016007|BDBM50056900|CCG-39250|NSC757318|s6404|STK301812|AKOS000120983|Tox21_111129_1|CS-7630|CS-O-07764|DB08797|LS-1556|NSC-757318|IDI1_000858|NCGC00091414-01|NCGC00091414-03|NCGC00091414-04|NCGC00091414-05|NCGC00091414-07|NCGC00256376-01|NCGC00259493-01|DS-16216|Salicylamide, puriss., >=99.0% (T)|SBI-0051509.P003|EU-0000058|FT-0659360|S0006|EN300-18542|SALICYLAMIDE, 2-HYDROXYBENZOICACIDAMIDE|D01811|F85552|AB00052089_12|A835120|AH-034/32461056|SR-01000721923|BENZOIC ACID,2-HYDROXY,AMIDE SALICYLAMIDE|J-509663|Q2496906|SR-01000721923-2|BRD-K81130846-001-02-6|BRD-K81130846-001-12-5|Z68590124|Salicylamide, United States Pharmacopeia (USP) Reference Standard|2-HYDROXYBENZAMIDE (SEE ALSO:N-HYDROXYBENZAMIDE (CAS 495-18-1))|Salicylamide, Pharmaceutical Secondary Standard; Certified Reference Material

Structure
3D structure 2D structure
5147
Predicted properties (NCBI Pubchem)

Physicochemical Properties